Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6) > Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6):827-32

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  PDT FOR NON-MELANOMA SKIN CANCER 

Giornale Italiano di Dermatologia e Venereologia 2018 December;153(6):827-32

DOI: 10.23736/S0392-0488.18.05977-1

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis

S. Morteza SEYED JAFARI 1, Simone CAZZANIGA 1, 2, Robert E. HUNGER 1

1 Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 2 Centro Studi GISED, Bergamo, Italy



INTRODUCTION: Mycosis fungoides is the most common cutaneous T cell lymphoma. Selection of appropriate treatment for mycosis fungoides (MF) is based on prognostic factors and overall clinical stage at diagnosis. In the past decade, clinical success has been reported using photodynamic therapy (PDT) as an alternative target-specific therapy to treat mycosis fungoides. This review aimed to summarize the current advances in management of mycosis fungoides by administration of photodynamic therapy.
EVIDENCE ACQUISITION: Twenty-four articles, published between 1994 and 2017, were reviewed to assess the efficacy of PDT for MF.
EVIDENCE SYNTHESIS: Methyl-aminolevulinic acid has increased lipophilic properties; red light at around 630 nm achieves deepest and best tissue penetration. However, the total number of PDT sessions depends on the clinical response.
CONCLUSIONS: Further multicenter clinical studies are warranted to assess the cost-effectiveness of PDT.


KEY WORDS: Mycosis fungoides - Photochemotherapy - Review

top of page